Ozempic May Slow Biological Aging: What the July 2026 Breakthrough Research Reveals
A July 14, 2026 study found semaglutide (Ozempic/Wegovy) slowed biological aging markers in adults with HIV — the first clinical evidence a drug may influence the pace of human aging. A 40-year pharmacist explains what this groundbreaking discovery means and what we know so far.